1. Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome. Issue 2 (8th December 2020) Authors: Tiraboschi, Carolina; Gentilini, Lucas; Velazquez, Carla; Corapi, Enrique; Jaworski, Felipe Martín; Garcia Garcia, José Daniel; Rondón, Yorfer; Chauchereau, Anne; Laderach, Diego José; Compagno, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers. (24th September 2013) Authors: Laderach, Diego J.; Gentilini, Lucas; Jaworski, Felipe M.; Compagno, Daniel Other Names: Gulley James L. Academic Editor. Journal: Prostate cancer Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Galectin‐1 Triggers Epithelial‐Mesenchymal Transition in Human Hepatocellular Carcinoma Cells. Issue 6 (June 2015) Authors: Bacigalupo, María L.; Manzi, Malena; Espelt, María V.; Gentilini, Lucas D.; Compagno, Daniel; Laderach, Diego J.; Wolfenstein‐Todel, Carlota; Rabinovich, Gabriel A.; Troncoso, María F. Journal: Journal of cellular physiology Issue: Volume 230:Issue 6(2015:Jun.) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗